Three oncology organizations weigh in on the CMS Medicare Physician Fee Schedule final rule for 2026, highlighting key pros ...

Novo, however, vastly underestimated the appetite for its new weight-loss jab. Mr Doustdar says it planned for demand to be three times that of Saxenda, an older and less-effective weight-loss drug.

The Centers for Medicare and Medicaid Services' Innovation Center last week unveiled MAHA ELEVATE, a new model that will fund ...

Here's what changes to Social Security payouts, tax deductions and Medicare premiums mean for retirees' cash flow in 2026.